Evidence map›Paper›PMID 35617279›Full record

ArticlePloS one2022

Kinin B1 receptor deficiency protects mice fed by cafeteria diet from abnormal glucose homeostasis.

Poliana E Correia, Clarissa B Gomes, Vinicius A Bandeira, Thais Marten, Gabriella R Natividade, Paula Merello, Erica Tozawa, Carlos T S Cerski, Alexandre Budu, Ronaldo Araújo and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Kinin receptors in adipose tissue: drivers of inflammation and metabolic dysfunction in obesity.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Poliana E CorreiaGraduation Program in Medical Science: Endocrinology, Department of Internal Medicine Faculty of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0001-7648-7378
Clarissa B GomesFaculty of Nutrition, Federal University of Pelotas, Pelotas, Brazil.
Vinicius A BandeiraFaculty of Nutrition, Federal University of Pelotas, Pelotas, Brazil.
Thais MartenFaculty of Nutrition, Federal University of Pelotas, Pelotas, Brazil.
Gabriella R NatividadeUniversidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0002-2811-3619
Paula MerelloUniversidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Erica TozawaUniversidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Carlos T S CerskiUniversidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Alexandre BuduDepartment of Biophysics, Universidade Federal de São Paulo, São Paulo, Brazil.
Ronaldo AraújoDepartment of Biophysics, Universidade Federal de São Paulo, São Paulo, Brazil.
Bruno D ArboUniversidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Maria Flávia M RibeiroDepartament of Physiology, Institute of Basic Health Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Carlos C BarrosFaculty of Nutrition, Federal University of Pelotas, Pelotas, Brazil.
Fernando GerchmanGraduation Program in Medical Science: Endocrinology, Department of Internal Medicine Faculty of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Universidade Federal do Rio Grande do Sul · BRUniversidade Federal de Pelotas · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The kallikrein-kinin system has been implicated in body weight and glucose homeostasis. Their major effectors act by binding to the kinin B2 and B1 receptors. It was assessed the role of the kinin B1 receptor in weight and glucose homeostasis in B1 receptor knockout mice (B1RKO) subjected to a cafeteria diet (CAF). Wild-type (WT) and B1RKO male mice (C57BL/6 background; 8 weeks old) were fed a standard diet (SD) or CAF for 14 weeks, ad libitum, and four groups were formed: WT-SD; B1RKO-SD; WT-CAF; B1RKO-CAF. Body weight and food intake were assessed weekly. It was performed glucose tolerance (GTT) and insulin tolerance tests (ITT), and HOMA-IR, HOMA-β and HOMA-β* 1/HOMA-IR were calculated. Islets from WT and B1RKO were isolated in order to measure the insulin secretion. Western blot was used to assess the hepatic AKT phosphorylation and qPCR to assess gene expression. CAF induced a higher body mass gain in B1RKO compared to WT mice. CAF diet increased epididymal fat depot mass, hepatic fat infiltration and hepatic AKT phosphorylation in both genotypes. However, B1RKO mice presented lower glycemic response during GTT when fed with CAF, and a lower glucose decrease in the ITT. This higher resistance was overcomed with higher insulin secretion when stimulated by high glucose, resulting in higher glucose uptake in the GTT when submitted to CAF, despite lower insulin sensitivity. Islets from B1RKO delivered 4 times more insulin in 3-month-old mice than islets from WT. The higher insulin disposition index and high insulin delivery of B1RKO can explain the decreased glucose excursion during GTT. In conclusion, CAF increased the β-cell function in B1RKO mice, compensated by the diet-induced insulin resistance and resulting in a healthier glycemic response despite the higher weight gain.

Indexed as

HyperinsulinismInsulin ResistanceAnimalsBlood GlucoseDietDiet, High-FatGlucoseHomeostasisInsulinKininsMaleMiceMice, Inbred C57BLMice, KnockoutProto-Oncogene Proteins c-aktReceptors, BradykininBlood GlucoseGlucoseInsulinKininsProto-Oncogene Proteins c-aktReceptors, Bradykinin

Identifiers

PMID35617279
PMCPMC9135186
OpenAlexW4281867474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.